v3.26.1
Schedule of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Net operating losses $ 15,937,614 $ 6,708,668
Foreign tax credits 172,102 139,978
Federal & state research credit carryforwards 16,186
Federal & state research credit carryforwards 4,959,544 2,530,635
Stock-based compensation 1,128,104 775,253
Amortization of capitalized research and development 3,027,057 5,599,397
Depreciation 20,960 10,623
Lease 29,672
Valuation allowance (25,291,239) (15,764,554)
Net deferred tax assets